👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

Dengue fever numbers soar on La Reunion - WHO

Published 05/21/2019, 06:24 PM
Updated 05/21/2019, 06:30 PM
Dengue fever numbers soar on La Reunion - WHO

GENEVA, May 21 (Reuters) - Tens of thousands of people are
thought to have caught dengue fever in an unprecedented outbreak
of the mosquito-borne disease on the French overseas territory
of La Reunion, the World Health Organization said on Tuesday.
Authorities in the popular Indian Ocean tourist destination
notified WHO of the outbreak in March 2018, since when 50,000
probable cases have been reported, including 22,000 so far this
year, the global health agency said in a statement.
Last year, 6,942 of the suspected cases were confirmed to be
dengue, a 6,000% increase from 2017. So far this year, there
have been 7,700 confirmed cases of the disease, which causes
flu-like illness and can kill.
"The upsurge of confirmed and probable cases reported in
2018 is unprecedented," said the WHO.
There is no specific treatment for dengue, but with early
detection and access to proper medical care fewer than 1% of
sufferers die from the disease.
WHO said 14 people have died in the Reunion outbreak since
2018.
Globally, the number of dengue cases dropped in 2017-2018,
but there has been a sharp increase in 2019, especially in
Australia, Cambodia, China, Laos, Malaysia, Philippines,
Singapore and Vietnam.
Reunion has a population of 866,500, according to French
official statistics.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.